Cigna Q4 EPS Soars 22% to $8.08 on Evernorth, PBM Strength
Cigna Group posted fourth-quarter adjusted EPS of $8.08, a 22% year-over-year gain that topped consensus by 2.7%, driven by new Evernorth Health Services wins and Pharmacy Benefit Services volume. The insurer saw medical customer counts decline after divestitures to Health Care Services Corporation while elevated expenses partially offset profitability.
1. Cigna Q4 Earnings Beat
Cigna delivered adjusted earnings per share of $8.08 for fourth-quarter 2025, outpacing the Zacks Consensus Estimate by 2.7% and marking a 22% increase from a year earlier. The strong bottom line was fueled by expanded client relationships at Evernorth Health Services and higher specialty volumes in its Pharmacy Benefit Services segment.
2. Membership Decline and Expense Pressure
Total medical membership dipped following divestitures to Health Care Services Corporation, offsetting some revenue gains. At the same time, an elevated expense base – including increased medical costs and administrative outlays – limited further margin expansion.
3. Segment Performance Highlights
Evernorth Health Services saw robust new business wins and client expansions, while Pharmacy Benefit Services benefited from improved specialty volumes. Outside these units, other core insurance operations faced margin headwinds from rising claims and benefit expense ratios.